Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Third party research

Ovzon: US a challenge, but strong outlook - ABG

Ovzon

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
- Strong Q2; sales +148% y-o-y and positive EBIT
- We make small EBIT revisions
- Strong near-term outlook, 32x-16x '25e-'26e EV/EBIT


Strong Q2 results

With sales +148% y-o-y and EBIT of SEK 27m (vs. SEK -17m in Q2'24), Ovzon delivered a strong Q2. This improvement was driven by recent contracts; in particular the SEK 1bn order from the Swedish Defence Materiel Administration (FMV), which has been a real game changer for Ovzon. We estimate that only ~SEK 65m of the 24-month contract has so far been recognised, and it should also be noted that another SEK 72m follow-up contract was signed after the end of the quarter. This means that the SEK 1.2bn Q2 backlog provides a strong outlook and comparably good visibility of estimates. Importantly, Ovzon demonstrated significant operational leverage on improved sales, driven by a 20pp GM expansion (due to increased capacity on Ovzon-3) and rigorous opex control.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.